Image: Pexels | Written by: Medical Companion Travel Content Team
Original articles, please do not reprint without permission
According to media reports, 7-year-old Chen Chen suffered from acute lymphoblastic leukemia (T type), and his stomach had been swollen like a ball.
Later, due to complications of pancreatitis, he was asked to fast and fast to water, and he was unable to eat for 6 days.
According to Chenchen's mother, after a month of chemotherapy, Chenchen's condition recurred again, and her family had to take her to Beijing for treatment. At the beginning, I was admitted to the ICU because of the serious reaction, and the road ahead is still very difficult, but the whole family is trying to persevere.
Netizens felt distressed after seeing the photos and hoped that ChenChen could recover as soon as possible.
At the same time, everyone also has a question, why ChenChen has not eaten for six days, and his stomach is still swollen like a ball?
Experts replied that this could be related to complications of leukemia.
Leukemia is a cancer of the body's hematopoietic tissues, including the bone marrow and lymphatic system. There are many types of leukemia, and some forms of leukemia are more common in children.
Symptoms of leukemia usually present with fever or chills, persistent fatigue, weakness, frequent or severe infection of lymphadenopathy, enlarged liver or spleen, easy bleeding or repeated nosebleeds from bruises, excessive sweating of small red dots (petechiae) on the skin, especially bone pain or tenderness at night.
Chen Chen's stomach was swollen, possibly due to enlarged liver or spleen caused by leukemia.
Leukemia is divided into multiple types, ChenChen's acute lymphoblastic leukemia is mostly common in children, in addition to the following types of leukemia.
A common type of leukemia
1. Acute lymphoblastic leukemia (ALL). This is the most common type of leukemia in young children. Acute lymphoblastic leukemia can also occur in adults.
2. Acute myeloid leukemia (AML). AML is a common type of leukemia. It occurs in children and adults. AML is the most common type of acute leukemia in adults.
3. Chronic lymphocytic leukemia (CLL). With CLL, the most common chronic adult leukemia, it is possible to feel good for years without the need for treatment.
4. Chronic myeloid leukemia (CML). This type of leukemia mainly affects adults. Patients with CML may have few symptoms for months or years before entering the phase of faster cell growth in leukemia.
5. Other types. Other, rarer types of leukemia are present, including hairy cell leukemia, myelodysplastic syndromes, and myeloproliferative disorders.
Each type of treatment regimen and the affected population is different, but the medical community generally believes that genetics, chemical influences, and smoking are major factors in increasing the chance of developing leukemia. I don't know whether Chenchen's condition is related to the above factors, but in any case, families with babies must take good measures to avoid children being affected by second-hand smoke, formaldehyde and other factors.
Leukemia as one of the ten major malignant tumors, has been concerned by the medical community in various countries, the corresponding drugs emerge in an endless stream, the following for you to list the main drugs of leukemia, for reference.
A pool of commonly used drugs for leukemia
Akatinib: the first second-generation BTK inhibitor, well tolerated, has been approved for the treatment of chronic lymphocytic leukemia (CLL).
Encidipine: An approved oral IDH2 inhibitor in the United States for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (R/R AML) with IDH2 mutations.
Ibutinib: The world's first BTK (Bruton tyrosine kinase) inhibitor for the treatment of patients with mantle cell lymphoma who have received at least one treatment in the past, and patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have received at least one treatment in the past.
Bendamustine: is a bifunctional alkylating agent with antitumor and cell-killing effects. For the treatment of chronic lymphocytic leukemia (CLL).
Geritinib: a second-generation FLT3 inhibitor with high selectivity for FLT3 mutations, stronger inhibitory effect and less off-target effect. Used to treat relapsed or refractory acute myeloid leukemia (AML) with positive FLT3 mutations.
It is important for parents to take precautions in their lives to reduce the risk of developing their children with the disease.